A paradigm-shifting study shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, offering hope for improving cognitive functioning, delaying Alzheimer's progression, and potentially preventing some of the brain damages associated with the disease.
Read more https://www.sciencedaily.com/releases/2025/02/250204141840.htm